Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resection

International Journal of Colorectal Disease

Volumn 28, Issue 3, 2013, Pages 415-424

  Tsai, Hsiang Lin ^a,b,c   Yang, I Ping ^d   Lin, Chih Hung ^b   Chai, Chee Yin ^a,b   Huang, Yu Ho ^a   Chen, Chin Fan ^b   Hou, Ming Feng ^a,b   Kuo, Chao Hung ^b   Juo, Suh Hang ^a,b   Wang, Jaw Yuan ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

^d Shu Zen College of Medicine and Management   (Taiwan)

Author keywords

Colorectal cancer; Disease free survival; Early relapse; Overall survival; VEGF

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

ADULT; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; DEMOGRAPHY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; POSTOPERATIVE PERIOD; RECURRENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84879464713     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1570-z     Document Type: Article

References (45)

1. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW (2005) Colorectal cancer. Lancet 365:153-165 (Pubitemid 40091806)
2. Frederiksen BL, Jorgensen T, Brasso K, Holten I, Osler M (2010) Socioeconomic position and participation in colorectal cancer screening. Br J Cancer 103:1496-1501
3. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277-300
4. Department of Health: cancer registry annual report, Taiwan, Republic of China. 2008. Department of Health, the Executive Yuan, Taipei, Republic of China, 2008
5. Korner H, Soreide K, Stokkeland PJ, Soreide JA (2005) Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance. J Gastrointest Surg 9:320-328 (Pubitemid 40327098)
6. Longo WE, Johnson FE (2002) The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surg Clin N Am 82:1091-1108 (Pubitemid 35463086)
7. O'Connell MJ, Campbell ME, Goldberg RM, Grothey A, Seitz JF, Benedetti JK, Andre T, Haller DG, Sargent DJ (2008) Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set. J Clin Oncol 26:2336-2341
8. Tsai HL, Chu KS, Huang YH, Su YC, Wu JY, Kuo CH, Chen CW, Wang JY (2009) Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. J Surg Oncol 100:736-743
9. Hiratsuka M, Miyashiro I, Ishikawa O, Furukawa H, Motomura K, Ohigashi H, Kameyama M, Sasaki Y, Kabuto T, Ishiguro S, Imaoka S, Koyama H (2001) Application of sentinel node biopsy to gastric cancer surgery. Surgery 129:335-340 (Pubitemid 32200064)
10. Buyse M, Piedbois P (2001) Should Dukes' B patients receive adjuvant therapy? A statistical perspective. Semin Oncol 28:20-24 (Pubitemid 32173100)
11. Zafirellis K, Agrogiannis G, Zachaki A, Gravani K, Karameris A, Kombouras C (2008) Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer. J Surg Res 147:99-107 (Pubitemid 351626074)
12. Wakui S, Furusata M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, Asano K, Tokuda T, Aziawa S, Ushigome S (1992) Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 168:257-262
13. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 324:1-8
14. Macchiarini P, Fontanini G, Hardin MJ, Squatini F, Angeletti CA (1992) Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet 340:145-146
15. Smithmaccune KK, Weidner N (1994) Demonstration and characterization of angiogenic properties of cervical dysplasia. Cancer Res 54:800-804 (Pubitemid 24068340)
16. Prins MJ, Verhage RJ, Ten Kate FJ, van Hillegersberg R (2012) Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma. J Gastrointest Surg 16:956-966
17. Nicosia RF, Nicosia SV, Smith M (1994) Vascular endothelial growth factor, platelet derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 145:1023-1029 (Pubitemid 24345649)
18. Pepper MS, Ferrara N, Orci L, Montesano R (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen-activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181:902-906
19. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK (1996) During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 2:992-997 (Pubitemid 26306837)
20. Madhi S, Eunice SW (2011) Vascular endothelial growth factor inhibition: conflicting roles in tumor growth. Cytokine 53:115-129
21. Ishigami SI, Arii S, Furutani M, Niwano M, Harada T, Mizumoto M, Mori A, Onodera H, Imamura H (1998) Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer 78:1379-1384 (Pubitemid 28495254)
22. Kuramochi H, Hayyashi K, Uchida K, Miyakura S, Shimizu D, Vallbohmer D, Park S, Danenberg KD, Takasaki K, Danenberg PV (2006) Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compared with corresponding primary colorectal cancer. Clin Cancer Res 12:29-33 (Pubitemid 43166172)
23. Altomare DF, Rotelli MT, Pentimone A, Rossiello MR, Martinelli E, Guglielmi A, De Fazio M, Marino F, Memeo V, Colucci M, Semeraro N (2007) Tissue factor and vascular endothelial growth factor expression in colorectal cancer: relation with cancer recurrence. Color Dis 9:133-138 (Pubitemid 46111596)
24. Hwang CC, Chai HT, Chen HW, Tsai HL, Lu CY, Yu FJ, Huang MY, Wang JY (2011) S100B protein expressions as an independent predictor of early relapse in UICC stage II and III colon cancer patients after curative resection. Ann Surg Oncol 18:139-145
25. Kobayashi H, Mochizuki H, Sugihara K, Morita T, Kotake K, Teramoto T, Kameoka S, Saito Y, Takahashi K, Hase K, Oya M, Maeda K, Hirai T, Kameyama M (2007) Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery 141:67-75 (Pubitemid 44918081)
26. Zhou W, Goodman SN, Galizia G, Lieto E, Ferraraccio F, Pignatelli C, Pardie CA, Piris J, Morris R, Harrison DJ, Paty PB, Culliford A, Romans KE, Montgomen EA, Choti MA, Kinzler KW, Vogelestein B (2002) Counting alleles to predict recurrence of early-stage colorectal cancer. Lancet 359:219-225 (Pubitemid 34113820)
27. Duffy MJ, van Dalen A, Haqlund C, Hansson L, Klapdor R, Lamerz R, Nilsson O, Sturgeon C, Topolcan O (2003) Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 39:718-727 (Pubitemid 36315986)
28. Saha D, Roman C, Beauchamp D (2002) New strategies for colorectal cancer prevention and treatment. World J Surg 26:762-766 (Pubitemid 36920314)
29. Allegra CJ, Paik S, Colangelo LH, Parr AL, Kirsch I, Kim G, Klein P, Johnston PG, Wolmark N, Weiand HS (2003) Prognostic value of thymidylate synthase, ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. J Clin Oncol 21:241-250 (Pubitemid 46606152)
30. Cascinu S, Graziano F, Catalano V, Staccioli MP, Rossi MC, Baldelli AM, Barni S, Brenna A, Secondino S, Muretto P, Catalano G (2002) An analysis of p53. BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumor recurrence and event-free survival of patients treated with adjuvant chemoradiation. Br J Cancer 86:744-749 (Pubitemid 34250817)
31. Grizzle WE, Manne U, Weiss HL, Jhala N, Talley L (2002) Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 and p27 (kip-1). Int J Cancer 97:403-409 (Pubitemid 34027796)
32. Chin KF, Greenman J, Gardiner E, Kumar H, Topping K, Monson J (2000) Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment for curative resection in colorectal cancer. Br J Cancer 83:1425-1431
33. Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K, Watanabe G (2004) Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor. J Thorac Cardiovasc Surg 128:517-522 (Pubitemid 39278384)
34. Des Guetz G, Uzzan B, Nicolas P, Cucherat M, Morere JF, Benamouzig R, Breau JL, Perret GY (2006) Microvessel density and VEGF expression are prognostic factors in colorectal cancer: meta-analysis of the literature. Br J Cancer 94:1823-1832 (Pubitemid 43882572)
35. Kim W, Sten S, Ib JC, Hans J, the Danish RANX05 Colorectal Cancer Study Group (2003) Circulating vascular endothelial growth factor six months after primary surgery as a prognostic marker in patients with colorectal cancer. Acta Oncologica 42:837-844 (Pubitemid 38091184)
36. Zhong C, Wei W, Su XK, Li HD, Xu FB, Guo RP (2012) Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection. Hepatogastroenterology 59:93-97
37. Ohm JE, Carbone DP (2001) VEGF as a mediator of tumor-associated immunodeficiency. Immunol Res 23:263-272 (Pubitemid 32575367)
38. Cascinu S, Graziano F, Valentini M, Catalano V, Giordani P, Staccioli MP, Rossi C, Baldelli AM, Grianti C, Murette P, Catalano G (2001) Vascular endothelial growth factor expression, s-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy. Ann Oncol 12:239-244 (Pubitemid 32223875)
39. Galizia G, Leito E, Ferraraccio F, Orditura M, De Vita F, Castellano P, Imperatore V, Romano C, Ciardiello F, Agostin B, Pignatelli C (2004) Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Clin Cancer Res 10:3490-3499 (Pubitemid 38685457)
40. Kaio E, Tanaka S, Kitadai Y, Sumii M, Yoshihara M, Haruma K, Chayama K (2003) Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma. Oncology 64:61-73 (Pubitemid 35477956)
41. Cascinu S, Staccioli MP, Gasparini G, Giordani P, Catalano V, Ghiselli R, Rossi C, Baldelli AM, Graziano F, Saba V, Muretto P, Catalano G (2000) Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer. Clin Cancer Res 6:2803-2807 (Pubitemid 30482120)
42. Nanni O, Volpi A, Frassineti GL, De Paola F, Granato AM, Dubini A, Zoli W, Scarpi E, Turci D, Oliverio G, Gambi A, Amadori D (2002) Role of biological markers in the clinical outcome of colon cancer. Br J Cancer 87:868-875 (Pubitemid 35252962)
43. Zheng S, Han MY, Xiao ZX, Peng JP, Dong Q (2003) Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma. World J Gastroenterol 9:1227-1230 (Pubitemid 36805657)
44. Ferroni P, Spila A, Martini F, D'Alessanodro R, Mariotti S, Del Monte G, Graziano P, Buonomo O, Guadagni F, Roselli M (2005) Prognostic value of vascular endothelial growth factor tumor tissue content of colorectal cancer. Oncology 69:145-153 (Pubitemid 41376913)
45. Kondo Y, Arii S, Furutani M, Isiqami S, Mori A, Onodera H, Chiba T, Imamura M (2000) Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma. Cancer 88:1820-1827 (Pubitemid 30212991)